These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30647906)

  • 1. HIV treatment and monitoring patterns in routine practice: a multi-country retrospective chart review of patient care.
    Musa BM; Ibekwe E; Mwale S; Eurien D; Oldenburg C; Chung G; Heller RF
    F1000Res; 2018; 7():713. PubMed ID: 30647906
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic.
    Carmody ER; Diaz T; Starling P; dos Santos AP; Sacks HS
    Trop Med Int Health; 2003 May; 8(5):378-85. PubMed ID: 12753630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to viral load testing guidelines, barriers, and associated factors among persons living with HIV on ART in Southwestern Uganda: a mixed-methods study.
    Lubega P; Nalugya SJ; Kimuli AN; Twinokusiima M; Khasalamwa M; Kyomugisa R; Kabami J; Owaraganise A
    BMC Public Health; 2022 Jun; 22(1):1268. PubMed ID: 35768800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short communication: east meets west: a description of HIV-1 drug resistance mutation patterns of patients failing first line therapy in PEPFAR clinics from Uganda and Nigeria.
    Crawford KW; Wakabi S; Kibuuka H; Magala F; Keshinro B; Okoye I; Akintunde E; Hamm TE
    AIDS Res Hum Retroviruses; 2014 Aug; 30(8):796-9. PubMed ID: 24798614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project.
    Okoboi S; Ekwaru PJ; Campbell JD; Egessa A; King R; Bakanda C; Muramuzi E; Kaharuza F; Malamba S; Moore DM
    BMC Public Health; 2016 Feb; 16():101. PubMed ID: 26830678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria.
    lsa SE; Gwamzhi LN; Akolo C; Giyan J
    Niger J Med; 2010; 19(3):279-85. PubMed ID: 20845631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provision of HIV viral load testing services in Zimbabwe: Secondary data analyses using data from health facilities using the electronic Patient Monitoring System.
    Apollo T; Takarinda KC; Phillips A; Ndhlovu C; Cowan FM
    PLoS One; 2021; 16(1):e0245720. PubMed ID: 33481931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral suppression among HIV-positive patients on antiretroviral therapy in northwestern Nigeria: an eleven-year review of tertiary care centre records, January 2009-December 2019.
    Abdullahi SB; Ibrahim OR; Okeji AB; Yandoma RI; Bashir I; Haladu S; Idris SA; Oseni TIA; Suleiman BM; Yahaya M; Aworh MK; Sufiyan MB
    BMC Infect Dis; 2021 Oct; 21(1):1031. PubMed ID: 34600477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries.
    Ambia J; Renju J; Wringe A; Todd J; Geubbels E; Nakiyingi-Miiro J; Urassa M; Lutalo T; Crampin AC; Kwaro D; Kyobutungi C; Chimbindi N; Gomez-Olive FX; Tlhajoane M; Njamwea B; Zaba B; Mee P
    BMC Health Serv Res; 2017 Nov; 17(1):758. PubMed ID: 29162065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda.
    Dansereau E; Gakidou E; Ng M; Achan J; Burstein R; DeCenso B; Gasasira A; Ikilezi G; Kisia C; Masters SH; Njuguna P; Odeny TA; Okiro EA; Roberts DA; Duber HC
    PLoS One; 2015; 10(8):e0135653. PubMed ID: 26275151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the completeness and accuracy of South African National Laboratory CD4 and viral load data: a cross-sectional study.
    Bassett IV; Huang M; Cloete C; Candy S; Giddy J; Frank SC; Parker RA
    BMJ Open; 2018 Aug; 8(8):e021506. PubMed ID: 30139898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descriptive analysis of World Health Organization-recommended second-line antiretroviral treatment: A retrospective cohort data analysis.
    Gumede SB; Fischer A; Venter WDF; Lalla-Edward ST
    S Afr Med J; 2019 Nov; 109(12):919-926. PubMed ID: 31865953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy, CD4, viral load, and disease stage in HIV patients in Saudi Arabia: a 2001-2013 cross-sectional study.
    Memish ZA; Al-Tawfiq JA; Filemban SM; Qutb S; Fodail A; Ali B; Darweeish M
    J Infect Dev Ctries; 2015 Jul; 9(7):765-9. PubMed ID: 26230128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
    Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
    PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging routine viral load testing to integrate diabetes screening among patients on antiretroviral therapy in Malawi.
    Singano V; van Oosterhout JJ; Gondwe A; Nkhoma P; Cataldo F; Singogo E; Theu J; Ching'ani W; Hosseinpour MC; Amberbir A
    Int Health; 2021 Feb; 13(2):135-142. PubMed ID: 32556207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.